CLAVTIC PLUS Dry

Stronger Protection Against Resistant Infections

6.6gm/30ml
Pharma
Antibacterial

Product highlights

  • Higher strength pediatric antibiotic formulation
  • Enhanced coverage against resistant bacteria
  • Broad-spectrum antibacterial action
  • Effective in respiratory and ENT infections
  • Improved clinical response in pediatric patients
CLAVTIC PLUS Dry Syrup combines higher strength Amoxicillin with Potassium Clavulanate for effective management of moderate to severe pediatric bacterial infections.
Dosage Form
Dry Syrup / Oral Suspension
Product Name
CLAVTIC PLUS Dry Syrup
Composition
Amoxicillin 400mg + Potassium Clavulanate 57mg
Therapeutic Segment
Pediatric Antibiotic / Anti-infective
Pharmacological Action
Broad-spectrum antibacterial with β-lactamase inhibitor protection
Mechanism
Amoxicillin inhibits bacterial cell wall synthesis while Potassium Clavulanate inhibits β-lactamase enzymes, enhancing antibiotic efficacy.
Key Clinical Benefits
  • Enhanced antibacterial potency
  • Effective against resistant respiratory pathogens
  • Improved treatment outcomes in pediatric infections
  • Broad-spectrum efficacy in ENT and respiratory infections
  • Better bacterial eradication with dual-action protection
Key Indications
  • Moderate to severe respiratory tract infections
  • ENT infections
  • Urinary tract infections
  • Skin and soft tissue infections
Administration
Reconstitute with water before use and administer orally after meals or as directed by the physician.
Recommended Usage
Dosage should be based on body weight and pediatrician’s recommendation.
Dosage Form
Dry Syrup / Oral Suspension
CLAVTIC PLUS Dry Syrup
Amoxicillin 400mg + Potassium Clavulanate 57mg
Pediatric Antibiotic / Anti-infective
Pediatric Antibiotic / Anti-infective
Amoxicillin inhibits bacterial cell wall synthesis while Potassium Clavulanate inhibits β-lactamase enzymes, enhancing antibiotic efficacy.
  • Enhanced antibacterial potency
  • Effective against resistant respiratory pathogens
  • Improved treatment outcomes in pediatric infections
  • Broad-spectrum efficacy in ENT and respiratory infections
  • Better bacterial eradication with dual-action protection
  • Moderate to severe respiratory tract infections
  • ENT infections
  • Urinary tract infections
  • Skin and soft tissue infections
Reconstitute with water before use and administer orally after meals or as directed by the physician.
Dosage should be based on body weight and pediatrician’s recommendation.

Explore Similar Products

Therapeutic Segments
0 +
Years of Operations
0 +
Key Brands
0 +
Quality Assurance
0 %

Request a Free Quote

Quick, customized pharma–nutra quotations.